Uncategorized
Ocular Therapeutix™ to Present at the 2018 JMP Securities Life Sciences Conference
BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix, Inc. (NASDAQ:OCUL) a biopharmaceutical company focused on the formulation, development and commercialization of innovative therapies for diseases and conditions of the eye, today announced that Antony Mattessich, President and Chief Executive Officer of Ocular Therapeutix, will present at the 2018 JMP Securities Life Sciences Conference on Wednesday, June 20, 2018 at 3:30 PM ET at the St. Regis New York Hotel in New York, NY. In addition to t